Aura Biosciences
AURA
81 hedge funds and large institutions have $329M invested in Aura Biosciences in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 31 increasing their positions, 24 reducing their positions, and 3 closing their positions.
233% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 3
217% more call options, than puts
Call options by funds: $1.09M | Put options by funds: $343K
29% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 24
10% more capital invested
Capital invested by funds: $300M → $329M (+$28.8M)
8% more funds holding
Funds holding: 75 → 81 (+6)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5.96% less ownership
Funds ownership: 80.27% → 74.31% (-6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$1.85M |
| 2 |
BlackRock
New York
|
+$1.33M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$998K |
| 4 |
Morgan Stanley
New York
|
+$867K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$751K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$20M |
| 2 |
Goldman Sachs
New York
|
-$7.85M |
| 3 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$1.11M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.11M |
| 5 |
RCM
Regency Capital Management
Honolulu,
Hawaii
|
-$838K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $1K | +$377 | +44 | +54% |
|
|
SAM
77
Smartleaf Asset Management
Boston,
Massachusetts
| $984 | +$935 | +109 | New |
|
|
AAP
78
Arax Advisory Partners
Denver,
Colorado
| $437 | – | – | – |
|
|
CPA
79
Capital Performance Advisors
Walnut Creek,
California
| $223 | +$214 | +25 | New |
|
|
GI
80
GAMMA Investing
Foster City,
California
| $223 | +$214 | +25 | New |
|
|
RIL
81
Rothschild Investment LLC
Chicago,
Illinois
| $134 | – | – | – |
|
82
Millennium Management
New York
| – | -$168K | -22,188 | Closed |
|
|
PFS
83
Prospera Financial Services
Dallas,
Texas
| – | -$122K | -16,181 | Closed |
|
|
EC
84
EntryPoint Capital
New York
| – | -$27K | -3,571 | Closed |
|
AURA Hedge Fund Activity: Q3 2024 in Review
81 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Aura Biosciences (AURA) for Q3 2024, worth a combined $329M — up 9.6% from $300M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new AURA positions and 3 closed out — a net gain of 7 holders — while 31 added to existing stakes and 24 trimmed.
The largest buyer was Franklin Resources, adding an estimated $1.85M. The largest seller was Citadel Advisors, cutting an estimated $20M.
- 81 institutional investors held Aura Biosciences (AURA) as of Q3 2024, up from 75 in Q2 2024.
- Funds reported $329M of Aura Biosciences stock for Q3 2024, up 9.6% quarter-over-quarter.
- 10 funds opened new Aura Biosciences positions in Q3 2024 and 3 closed out, a net change of +7 holders.
- The largest Aura Biosciences buyer in Q3 2024 was Franklin Resources, an estimated $1.85M added.
- The largest Aura Biosciences seller in Q3 2024 was Citadel Advisors, an estimated $20M sold.
Based on aggregated 13F filings for Q3 2024.